Omeros (OMER) FCF Margin (2010 - 2026)
Omeros (OMER) posted FCF Margin of 146.63% for Q1 2026, up 23.92% sequentially from 192.72% in Q2 2022.
Powered by 
Analysis
Omeros (OMER) FCF Margin (2010 - 2026) Analysis & Trends
Omeros has reported FCF Margin for 14 years, with the latest figure at 146.63% in Q1 2026.
- Quarterly FCF Margin changed N/A year-over-year to 146.63% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 351.17% (down 57893.0% YoY) and the FY2020 annual result came in at 135.98%, down 8195.0% from the prior year.
- FCF Margin rose to 146.63% in Q1 2026 per OMER's latest filing, from 192.72% in the prior quarter.
- Over five years, FCF Margin peaked at 146.63% in Q1 2026 and troughed at 217.17% in Q1 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -388.28% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.68% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 22.62% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 70.82% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -22.35% |
| 10 | Omeros | 1.38 Bn | 1.38 Bn | 27.73 Mn | 14.39% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.39% |
| Mar 31, 2026 | -146.63% |
| Jun 30, 2022 | -192.72% |
| Mar 31, 2022 | -217.17% |
| Dec 31, 2021 | -59.29% |
| Sep 30, 2021 | -79.20% |
| Jun 30, 2021 | -96.03% |
| Mar 31, 2021 | -191.19% |
| Dec 31, 2020 | -173.13% |
| Sep 30, 2020 | -134.08% |
| Jun 30, 2020 | -278.94% |
| Mar 31, 2020 | -39.12% |
| Dec 31, 2019 | -68.92% |
| Sep 30, 2019 | -25.32% |
| Jun 30, 2019 | -62.37% |
| Mar 31, 2019 | -60.29% |
| Dec 31, 2018 | -112.41% |
| Sep 30, 2018 | -802.13% |
| Jun 30, 2018 | -1,879.94% |
| Mar 31, 2018 | -722.86% |